| MNK-395, topical diclofenac sodium 2%, transdermal diclofenac sodium 2% | |
| diclofenac sodium | |
| Horizon Pharma plc | |
| HZNP | |
| Non | |
| Development Outside U.S. | |
| Small Molecule | |
| Cyclooxygenases (COX-1, COX-2, and COX-3) | |
| Non-NME | |
| Topical, Transdermal |
Fiche créée le 23/02/2016 par 
Guillaume vue 4 fois.